Alexander C. Schmidt

Author

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

A Schmidt, A. C. Schmidt, A. Schmidt, Alexander C Schmidt, Alexander C. Schmidt, Alexander Schmidt, Dennis J. Pierro, Manish Joshi, Michael T. Rock

Publications

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health GlaxoSmithKline (United States)Johns Hopkins University University of North Carolina at Chapel Hill

About

Alexander C. Schmidt is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1.6K
2	Public Health	4	4	862
3	Epidemiology	4	4	883
4	Global Health	3	3	839
5	Cell Biology	2	2	47

Alexander C. Schmidt

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms Guido España, Cosmina Hogea, Adrienne Guignard, PLoS ONE VaccinationDengue Vaccine CandidatesInfectious Disease ModellingPreventive MedicineHeterogeneous Exposure	2019	734
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis Eric W.F.W. Alton, Jeffrey M. Beekman, A. Christopher Boyd, Thorax Translational MedicineLung Gene TransferViral DiagnosticsViral PathogenesisPharmacology	2016	141
Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3 Alexander C. Schmidt, Josephine M. McAuliffe, Brian R. Murphy, Journal of Virology	2001	107
Immune correlates of protection for dengue: State of the art and research agenda Leah C. Katzelnick, Eva Harris, Ralph S. Baric, Vaccine VaccinationResearch AgendaHumoral ResponseImmunologyVector Control	2017	95
Bovine Parainfluenza Virus Type 3 (BPIV3) Fusion and Hemagglutinin-Neuraminidase Glycoproteins Make an Important Contribution to the Restricted Replication of BPIV3 in Primates Alexander C. Schmidt, Josephine M. McAuliffe, Anne Huang, Journal of Virology VaccinationVirus StructureViral ReplicationMolecular VirologyMedicine	2000	89
Mucosal Immunization of Rhesus Monkeys against Respiratory Syncytial Virus Subgroups A and B and Human Parainfluenza Virus Type 3 by Using a Live cDNA-Derived Vaccine Based on a Host Range-Attenuated Bovine Parainfluenza Virus Type 3 Vector Backbone Alexander C. Schmidt, Daniel R. Wenzke, Josephine M. McAuliffe, Journal of Virology	2002	85
Response to Dengue Fever — The Good, the Bad, and the Ugly? Alexander C. Schmidt New England Journal of Medicine Dengue VirusHumoral ResponseImmunologyDisease OutbreakVirus Transmission	2010	67
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States Alexander C. Schmidt, Leyi Lin, Luis Javier Martínez-González, American Journal of Tropical Medicine and Hygiene	2017	64
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children Ruth A. Karron, Bhagvanji Thumar, Elizabeth Schappell, Vaccine VaccinationVeterinary VaccineVaccine DevelopmentImmunologyVaccine Testing	2011	56
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials Jason D. Lickliter, Tino F. Schwarz, Casey Johnson, The Journal of Infectious Diseases	2018	46

Page 1